Furthermore, Vγ9δ2 T cells have been considered as potential candidates for immunotherapy because they recognize antigens in an MHC-independent manner and therefore should not induce graft-versus-host disease (GvHD) [48]. This evidence concerns the gene HLA-C and graft versus host disease.